← Back to toolboxBenefits & risks

Complete response

Complete response · CR

Disappearance of all target lesions under the prespecified criteria. RECIST 1.1 also requires pathological lymph nodes to have a short axis below 10 mm; overall CR depends on non-target and new-lesion assessment.

How to read it

Check the criteria, assessment methods, other lesions and new lesions, plus any confirmation and duration requirements in the protocol.

A common pitfall

Complete response is not cure and alone does not determine when to stop treatment. The diagram illustrates the assessment concept.

Disappearance is assessed under the study criteria, including other lesions and the absence of new lesions. Complete response is not cure; numbers are illustrative.

Partial and complete response teaching diagramView full-size diagram ↗
© Before the Conclusion · Original concept, AI-assisted production

Read it in context

How Far Must Medicine Go to Spare One More Operation? →When a new drug is “effective,” what has it proved? (Part 1) →Do More Sensitive Measures Necessarily Mean Patients Benefit? (Part 2) →Should a Good Doctor Dare to Say “I Don't Know”? →After Phase III Success, How Should Investors Do the Math? →

Source

Read the primary source ↗

Explanations by Before the Conclusion · November 6, 2026